newsfilter
← Latest News
GlobeNewswire·

Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference

NOVATO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and